Medicare Enrolled
Dr. Majed Zouhairi, MD
Gastroenterology · New Windsor, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zouhairi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zouhairi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zouhairi
Dr. Majed Zouhairi is a gastroenterology specialist in New Windsor, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Zouhairi performed 1,033 Medicare services across 788 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zouhairi received a total of $9,635 from 62 pharmaceutical and/or device companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zouhairi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 23% volume in NY
$9,635 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,033
Medicare services
Top 23% in NY for gastroenterology
788
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $96 | $337 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
163 | $103 | $265 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $71 | $237 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
100 | $150 | $506 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
77 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
56 | $8 | $19 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
47 | $10 | $26 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
42 | $305 | $1,125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $128 | $438 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
36 | $257 | $1,320 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
33 | $49 | $128 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $25 | $60 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $76 | $292 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
23 | $411 | $1,304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $65 | $181 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
12 | $667 | $2,306 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,635
Total received (2018-2024)
Avg $1,376/year across 7 years
Top 21% in NY for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
415
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,635 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,260
2023
$2,003
2022
$946
2021
$1,144
2020
$940
2019
$1,009
2018
$1,333
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$268
Intercept Pharmaceuticals, Inc.
$258
Janssen Biotech, Inc.
$232
Regeneron Healthcare Solutions, Inc.
$162
CapsoVision, Inc.
$158
GENZYME CORPORATION
$126
Gilead Sciences, Inc.
$111
Lilly USA, LLC
$86
Celgene Corporation
$84
Boston Scientific Corporation
$82
Ardelyx, Inc.
$70
AIMMUNE THERAPEUTICS, INC.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$58
Phathom Pharmaceuticals, Inc.
$45
PFIZER INC.
$35
Merck Sharp & Dohme LLC
$32
Antares Pharma, Inc.
$31
Sumitomo Pharma America, Inc.
$30
Alnylam Pharmaceuticals Inc.
$28
Myriad Genetic Laboratories, Inc.
$25
UROGEN PHARMA, INC.
$24
Olympus America Inc.
$24
Celltrion USA Inc.
$22
PROCEPT BioRobotics Corporation
$22
180 Medical, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$19
Amgen Inc.
$17
Teleflex LLC
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Hollister Incorporated
$15
ABC Home Medical Supply, Inc.
$15
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,087
Gilead Sciences, Inc.
$835
Janssen Biotech, Inc.
$715
AbbVie, Inc.
$525
AbbVie Inc.
$507
BOSTON SCIENTIFIC CORPORATION
$407
PFIZER INC.
$407
Intercept Pharmaceuticals, Inc.
$406
GENZYME CORPORATION
$380
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$344
Antares Pharma, Inc.
$305
Regeneron Healthcare Solutions, Inc.
$277
Takeda Pharmaceuticals U.S.A., Inc.
$233
Celgene Corporation
$218
UroGen Pharma, Inc.
$213
Allergan Inc.
$211
Ferring Pharmaceuticals Inc.
$183
Axonics, Inc.
$178
CapsoVision, Inc.
$158
Boston Scientific Corporation
$152
Braintree Laboratories, Inc.
$148
Novo Nordisk Inc
$125
Ardelyx, Inc.
$121
E.R. Squibb & Sons, L.L.C.
$118
Janssen Scientific Affairs, LLC
$103
QOL Medical, LLC
$89
Lilly USA, LLC
$86
RedHill Biopharma Inc.
$80
AIMMUNE THERAPEUTICS, INC.
$69
Alnylam Pharmaceuticals Inc.
$67
180 Medical, Inc.
$66
Myriad Genetic Laboratories, Inc.
$66
Endo Pharmaceuticals Inc.
$57
Nestle HealthCare Nutrition Inc.
$55
Phathom Pharmaceuticals, Inc.
$45
Romark Laboratories, LC
$42
Bayer Healthcare Pharmaceuticals Inc.
$33
Merck Sharp & Dohme LLC
$32
Supernus Pharmaceuticals, Inc.
$31
Sumitomo Pharma America, Inc.
$30
Alfasigma USA, Inc.
$27
Merck Sharp & Dohme Corporation
$27
Tolmar, Inc.
$25
UROGEN PHARMA, INC.
$24
Olympus America Inc.
$24
Fresenius Kabi USA, LLC
$22
AstraZeneca Pharmaceuticals LP
$22
Celltrion USA Inc.
$22
PROCEPT BioRobotics Corporation
$22
Allergan, Inc.
$21
UCB, Inc.
$20
PROGENICS PHARMACEUTICALS, INC.
$19
Orexigen Therapeutics, Inc.
$18
TherapeuticsMD, Inc.
$18
Amgen Inc.
$17
Teleflex LLC
$17
Hollister Incorporated
$15
ABC Home Medical Supply, Inc.
$15
Shionogi Inc
$15
UROVANT SCIENCES INC
$14
Evoke Pharma, Inc.
$13
Acerus Pharmaceuticals Corporation
$13
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ACQUIRE · ADVANIX · ANNOVERA · AQUABEAM SYSTEM · AXIOS · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Axonics · Axonics r-SNM System · CIMZIA · CLENPIQ · CONTRAVE · CRE PRO · CREON · CapsoCam Plus · Cimzia · Creon · DIFICID · DOPTELET · DUPIXENT · ELIGARD · ENTYVIO · EOHILIA · ERLEADA · EVENITY · Entyvio · Epclusa · GATTEX · GEMTESA · GENTLECATH · GIMOTI · GIVLAARI · GentleCath · HUMIRA · Humira · IBSRELA · INFLECTRA · JELMYTO · KEYTRUDA · LINZESS · LUPRON DEPOT · MAVYRET · MOTOFEN · Mavyret · Mulpleta · NASCOBAL · NOCDURNA · Natesto · Nubeqa · OCALIVA · OMVOH · ORGOVYX · OTREXUP · PROLARIS · PYLARIFY · REMICADE · RINVOQ · SAPHNELO · SELF CATH · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Single Use Aspiration Needle NA-U200H · Spyglass · Sucraid · TREMFYA · TRULANCE · Talicia · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · Wegovy · X-Tack Endoscopic HeliX Tacking System · XELJANZ · XIFAXAN · XYOSTED · ZENPEP · ZEPBOUND · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
83
Per 100K population
20.6
County median income
$96,497
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zouhairi is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NY), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zouhairi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zouhairi performed 214 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zouhairi receive payments from pharmaceutical companies?
Yes. Dr. Zouhairi received a total of $9,635 from 62 companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zouhairi's costs compare to other gastroenterologists in New Windsor?
Dr. Zouhairi's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zouhairi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in New Windsor
Browse gastroenterologists in New Windsor ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NY
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NY
Which NY gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology